MDxHealth SA (NASDAQ:MDXH) Short Interest Up 81.0% in March

MDxHealth SA (NASDAQ:MDXH) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 56,300 shares, an increase of 81.0% from the February 28th total of 31,100 shares. Currently, 0.3% of the company’s stock are short sold. Based on an average daily volume of 104,100 shares, the days-to-cover ratio is presently 0.5 days.

MDxHealth Stock Down 0.7 %

NASDAQ:MDXH traded down $0.01 on Friday, reaching $1.51. 42,930 shares of the stock traded hands, compared to its average volume of 85,028. The company has a current ratio of 1.54, a quick ratio of 1.45 and a debt-to-equity ratio of 3.14. The company has a market capitalization of $71.40 million, a price-to-earnings ratio of -0.99 and a beta of 1.37. MDxHealth has a 12 month low of $1.35 and a 12 month high of $3.50. The company’s fifty day simple moving average is $1.75 and its 200 day simple moving average is $2.00.

MDxHealth (NASDAQ:MDXH) last issued its earnings results on Wednesday, February 26th. The company reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.07. The business had revenue of $24.74 million during the quarter, compared to analyst estimates of $22.67 million. MDxHealth had a negative return on equity of 1,077.84% and a negative net margin of 49.52%. Equities analysts predict that MDxHealth will post -1.15 EPS for the current fiscal year.

Institutional Trading of MDxHealth

Hedge funds have recently bought and sold shares of the company. Maven Securities LTD bought a new stake in shares of MDxHealth during the 3rd quarter valued at about $208,000. Oppenheimer & Co. Inc. boosted its holdings in shares of MDxHealth by 100.0% in the fourth quarter. Oppenheimer & Co. Inc. now owns 20,000 shares of the company’s stock worth $47,000 after buying an additional 10,000 shares during the last quarter. Perkins Capital Management Inc. grew its position in MDxHealth by 31.6% during the fourth quarter. Perkins Capital Management Inc. now owns 983,475 shares of the company’s stock valued at $2,331,000 after buying an additional 236,100 shares during the period. Geode Capital Management LLC purchased a new stake in MDxHealth during the fourth quarter valued at approximately $25,000. Finally, Samjo Management LLC raised its position in MDxHealth by 130.9% in the fourth quarter. Samjo Management LLC now owns 1,824,312 shares of the company’s stock worth $4,324,000 after acquiring an additional 1,034,312 shares during the period.

MDxHealth Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.